These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
405 related articles for article (PubMed ID: 25345238)
1. Adolescent angst or true intent? Suicidal behavior, risk, and neurobiological mechanisms in depressed children and teenagers taking antidepressants. Morrison J; Schwartz TL Int J Emerg Ment Health; 2014; 16(1):247-50. PubMed ID: 25345238 [TBL] [Abstract][Full Text] [Related]
2. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)]. Hjalmarsson L; Corcos M; Jeammet P Encephale; 2005; 31(3):309-16. PubMed ID: 16142045 [TBL] [Abstract][Full Text] [Related]
3. Antidepressants use in pediatric populations. Gören JL Expert Opin Drug Saf; 2008 May; 7(3):223-5. PubMed ID: 18462180 [TBL] [Abstract][Full Text] [Related]
4. The role of 5-HT1A receptors in mediating acute negative effects of antidepressants: implications in pediatric depression. Rahn KA; Cao YJ; Hendrix CW; Kaplin AI Transl Psychiatry; 2015 May; 5(5):e563. PubMed ID: 25942044 [TBL] [Abstract][Full Text] [Related]
5. Effects of vilazodone on suicidal ideation and behavior in adults with major depressive disorder or generalized anxiety disorder: post-hoc analysis of randomized, double-blind, placebo-controlled trials. Thase ME; Edwards J; Durgam S; Chen C; Chang CT; Mathews M; Gommoll CP Int Clin Psychopharmacol; 2017 Sep; 32(5):281-288. PubMed ID: 28538024 [TBL] [Abstract][Full Text] [Related]
6. The association between suicidality and treatment with selective serotonin reuptake inhibitors in older people with major depression: a systematic review. KoKoAung E; Cavenett S; McArthur A; Aromataris E JBI Database System Rev Implement Rep; 2015 Apr; 13(3):174-205. PubMed ID: 26447056 [TBL] [Abstract][Full Text] [Related]
7. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy. Akiskal HS; Benazzi F; Perugi G; Rihmer Z J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694 [TBL] [Abstract][Full Text] [Related]
8. [Efficacy of atypical antipsychotics in depressive syndromes]. Quintin P; Thomas P Encephale; 2004; 30(6):583-9. PubMed ID: 15738862 [TBL] [Abstract][Full Text] [Related]
9. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. Bridge JA; Iyengar S; Salary CB; Barbe RP; Birmaher B; Pincus HA; Ren L; Brent DA JAMA; 2007 Apr; 297(15):1683-96. PubMed ID: 17440145 [TBL] [Abstract][Full Text] [Related]
10. Does the FDA proposed list of possible correlates of suicidality associated with antidepressants apply to an adult private practice population? Akiskal HS; Benazzi F J Affect Disord; 2006 Aug; 94(1-3):105-10. PubMed ID: 16766043 [TBL] [Abstract][Full Text] [Related]
11. Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts. Schneeweiss S; Patrick AR; Solomon DH; Dormuth CR; Miller M; Mehta J; Lee JC; Wang PS Pediatrics; 2010 May; 125(5):876-88. PubMed ID: 20385637 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of antidepressants in pediatric anxiety disorders: a systematic review and meta-analysis. Strawn JR; Welge JA; Wehry AM; Keeshin B; Rynn MA Depress Anxiety; 2015 Mar; 32(3):149-57. PubMed ID: 25449861 [TBL] [Abstract][Full Text] [Related]
13. Suicidality in pediatric patients treated with antidepressant drugs. Hammad TA; Laughren T; Racoosin J Arch Gen Psychiatry; 2006 Mar; 63(3):332-9. PubMed ID: 16520440 [TBL] [Abstract][Full Text] [Related]
14. Antidepressants and the FDA's black-box warning: determining a rational public policy in the absence of sufficient evidence. Ho D Virtual Mentor; 2012 Jun; 14(6):483-8. PubMed ID: 23351264 [No Abstract] [Full Text] [Related]
15. Pharmacotherapy in depressed children and adolescents. Taurines R; Gerlach M; Warnke A; Thome J; Wewetzer C World J Biol Psychiatry; 2011 Sep; 12 Suppl 1():11-5. PubMed ID: 21905988 [TBL] [Abstract][Full Text] [Related]
16. [Clinical relevance of antidepressant-induced activation syndrome: from a perspective of bipolar spectrum disorder]. Tanaka T; Inoue T; Suzuki K; Kitaichi Y; Masui T; Denda K; Koyama T Seishin Shinkeigaku Zasshi; 2007; 109(8):730-42. PubMed ID: 17969991 [TBL] [Abstract][Full Text] [Related]
17. An increase in IL-6 levels at 6-month follow-up visit is associated with SSRI-emergent suicidality in high-risk children and adolescents treated with fluoxetine. Amitai M; Taler M; Lebow M; Ben-Baruch R; Apter A; Fennig S; Weizman A; Chen A Eur Neuropsychopharmacol; 2020 Nov; 40():61-69. PubMed ID: 32747326 [TBL] [Abstract][Full Text] [Related]
18. Which SSRIs most effectively treat depression in adolescents? DeLucia V; Kelsberg G; Safranek S J Fam Pract; 2016 Sep; 65(9):632-4. PubMed ID: 27672691 [TBL] [Abstract][Full Text] [Related]
19. Do antidepressants t(h)reat(en) depressives? Toward a clinically judicious formulation of the antidepressant-suicidality FDA advisory in light of declining national suicide statistics from many countries. Rihmer Z; Akiskal H J Affect Disord; 2006 Aug; 94(1-3):3-13. PubMed ID: 16712945 [TBL] [Abstract][Full Text] [Related]
20. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents. Hetrick S; Merry S; McKenzie J; Sindahl P; Proctor M Cochrane Database Syst Rev; 2007 Jul; (3):CD004851. PubMed ID: 17636776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]